person

Elena C.

Country
Spain
Department
Hematología

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
12
Sites with multiple studies

Has run more than one trial at 12 of 52 partner sites.

Specializations

Hematologic Oncology

This investigator specializes in the treatment of multiple myeloma, with particular focus on developing innovative therapeutic approaches for patients with relapsed and refractory disease states.

  • Advanced Multiple Myeloma Management
  • Refractory Disease Treatment
  • Novel Therapy Combinations

The investigator's work encompasses targeted therapy development for hematologic malignancies, specifically exploring new treatment options for patients who have developed resistance to conventional therapies.

Therapeutic Innovation

Research interests center on investigating combination therapy approaches that integrate novel agents with established treatments to enhance therapeutic outcomes in blood cancers.

  • Targeted Antibody Therapeutics
  • Proteasome Inhibitor Therapy
  • Combination Treatment Strategies

The investigator focuses on developing treatment protocols that combine different therapeutic mechanisms to overcome drug resistance in hematologic malignancies.

Clinical Assessment

Expertise includes evaluation of treatment response and safety profiles in complex hematologic conditions, with particular attention to measuring therapeutic efficacy through various clinical parameters.

  • Response Rate Assessment
  • Minimal Residual Disease Monitoring
  • Safety Profile Evaluation

The investigator specializes in monitoring treatment outcomes and determining optimal dosing strategies for novel therapeutic combinations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.